Evidence mapPaperPMID 40140909Full record

ArticleDiabetology & metabolic syndrome2025

Rising tide: the growing global burden and inequalities of early-onset type 2 diabetes among youths aged 15-34 years (1990-2021).

Yang Zhou, Yupeng Chen, Yiting Tang, Shan Zhang, Zifan Zhuang, Qing Ni

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yang Zhou *Department of Endocrinology, Guang'Anmen Hospital of China Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beixiange 5, Xicheng District, Beijing, 100053, China.
Yupeng Chen *Department of Endocrinology, Guang'Anmen Hospital of China Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beixiange 5, Xicheng District, Beijing, 100053, China.
Yiting Tang *Beijing University of Chinese Medicine, Beijing, China.
Shan ZhangDepartment of Endocrinology, Guang'Anmen Hospital of China Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beixiange 5, Xicheng District, Beijing, 100053, China.
Zifan ZhuangDepartment of Endocrinology, Guang'Anmen Hospital of China Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beixiange 5, Xicheng District, Beijing, 100053, China.
Qing NiDepartment of Endocrinology, Guang'Anmen Hospital of China Academy of Chinese Medical Sciences, Guang'anmen Hospital, Beixiange 5, Xicheng District, Beijing, 100053, China. niqing@gamyy.cn.

Funding

National Key Research and Development Program of China 2024ZD0523500National Natural Scientific Foundation of China 82174354
6 · The paper itself

Abstract

backgroundType 2 diabetes mellitus (T2DM) is increasingly affecting people aged 15-34, posing a serious public health challenge due to its faster progression and higher complication risks. This study examines the global, regional, and national burden of early-onset T2DM from 1990 to 2021, emphasizing trends and disparities across different sociodemographic contexts.

methodsUsing data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, we analyzed incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) in people aged 15-34. Stratifications included age, sex, and the Socio-Demographic Index (SDI). Joinpoint regression significant temporal shifts, and decomposition analysis attributed changes in T2DM burden to factors such as prevalence, population growth, aging, and case fatality rates. Inequality was assessed with the Slope Index of Inequality and Concentration Index.

resultsFrom 1990 to 2021, early-onset T2DM incidence and prevalence rose significantly worldwide, especially in high-SDI regions. Although global mortality and DALYs appeared relatively stable, low-SDI regions showed worrisome increases. Rising T2DM prevalence was the principal driver of mortality and DALYs, notably in low- and middle-SDI regions. Inequality analyses indicated widening disparities, with higher incidence and prevalence in high-SDI countries and more severe outcomes in low-SDI countries.

conclusionsThe global burden of early-onset T2DM among youths is escalating, with significant disparities across different sociodemographic levels. The findings underscore the urgent need for targeted public health interventions. Future research should focus on the underlying factors driving these trends and explore strategies for effective prevention and management of early-onset T2DM.

Indexed as

AdolescentsEarly-onset diabetesGBD 2021Global burdenPublic healthSociodemographic disparitiesType 2 diabetes mellitusYoung adults

Identifiers

PMID40140909
PMCPMC11948681

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.